Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116396950A reveals a novel carboxylesterase mutant for efficient (R)-3-cyclohexene-1-carboxylic acid production, offering superior stereoselectivity and scalable biocatalysis for API intermediates.
Patent CN121471179A reveals a green synthesis route for tetra (2-hydroxyethyl) furan diamide. This method offers high purity and cost reduction in coating material manufacturing.
Patent CN111875591B details a green one-pot synthesis for benzopyrone intermediates using recyclable ionic liquids, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN108659094A reveals efficient Mycoleptodiscin A synthesis. Enables cost reduction in fine chemical manufacturing and reliable supply chain for high-purity intermediates.
Advanced oxidation method for 2-nitro-4-methylsulfonylbenzoic acid intermediates. Reduces catalyst toxicity and improves supply chain reliability for global pharmaceutical manufacturing.
Patent CN111549008B reveals a novel AcATA mutant for sitagliptin intermediates. Achieves 90% conversion with superior purity and reduced environmental impact for pharma supply chains.
Patent CN118374465B reveals enzymatic route for (S)-nicotine. Achieves 99.1% ee value. Offers scalable biocatalysis for reliable pharmaceutical intermediates supplier chains.
Patent CN105734028A reveals high-efficiency epoxide hydrolase mutants for R-epichlorohydrin production, offering superior stability and supply chain reliability.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Patent CN108026130B reveals enzyme mutant method for NMN. Low cost, high purity, scalable supply chain solution for global buyers.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Patent CN114426508A reveals a novel one-pot synthesis for beta-carotene intermediates. Achieve >90% yield with simplified purification and reduced operational costs.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN106282135A details a robust RrQR enzyme process for (R)-3-quinuclidinol, offering superior stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN113651864A reveals a safer synthesis route for Diquafosol Tetrasodium using inorganic ammonia, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Visible light photocatalysis method for beta-methoxy fatty acid esters. Metal-free, green process offering supply chain stability and cost efficiency for fine chemical manufacturing.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.